I'm Not Worried About Scott Gottlieb's Resignation

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Cannabis Profits Daily. If you have any questions or would like to change free your email settings, please reference the contact information at the bottom of this email. [Cannabis Profits Daily] Monday, March 11, 2019 [Scott Gottlieb's Resignation Won't Derail the Cannabis Industry]( By Greg Miller I'm not going to sugarcoat it - the stock market was brutal last week. The Dow Jones Industrial Average fell mostly thanks to a bleak outlook from the European Central Bank and disappointing U.S. job growth numbers for February, and cannabis stocks followed the overall market into a dip. However, some believe the resignation of FDA Commissioner Scott Gottlieb also pushed cannabis stock prices down. In the stock market, retail investors hate uncertainty. It causes them to expect the worst and panic sell. For this particular situation, the FDA's responsibility for regulating CBD is creating some fear that Gottlieb's eventual replacement will have a harsher stance on regulations. But I'm here to tell you that, while this is newsworthy, it's not worth blowing out of proportion. There is going to be a fight between the FDA and CBD industry - which I will have more about later this week - but it's not going to be the one you're hearing about between [New York City and coffee shop owners]( serving CBD-infused cappuccinos. The picks in our portfolio are going to be just fine, and I even sent out an alert about buying a new cannabis stock because it was a great time to add a position. [So if you're a cannabis investor, I don't want you to panic, and I want you to have the full details about what Gottlieb's resignation really means...]( [Three Indispensable Cannabis Industry Bellwethers to Watch Before Making Your Trades]( [This Used to Be Reserved for America's Elite Traders, Now Everyday Investors Are Making a Killing]( [No, Aphria Did Not Crash Cannabis Stocks]( This Is the Kind of Rare Opportunity Investors Dream About Here at the Institute, we constantly hear from small, privately held cannabis companies.... And, to be blunt, most of these firms have no chance. However, a few times a year, something extraordinary happens... We come across [a startup that's set to rock the entire cannabis industry](. We find what could be the next multibillion-dollar company. Which is why I'm reaching out to you today. I want to take you on a journey - right now - with a company that has [the potential to grow 54,000%]( over the next few years. That's the equivalent of going [from a small $50 million company into a $52.5 billion behemoth](, practically overnight. And we've uncovered the only way you can get access to this deal right now. This is nothing like buying a public stock. This is not about IPO investing. Today, you're going to discover the [ins and outs of angel investing and venture capital](. All you have to do is [click here]( to learn more. This is the [ultimate pot stock investing tool]( - and it contains information on hundreds of the biggest, most tradeable cannabis stocks. Our highly secured platform has real data on the industry's best up-and-coming cannabis companies, so you can locate tomorrow's winners on your own - and for LIFE. [Click the link below to see the details](. --------------------------------------------------------------- You are receiving this e-mail at {EMAIL}, as a part of your subscription. Remove your email from this list: [Unsubscribe]( © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 [Contact Customer Service](mailto:support@nicinvestors.com?subject=Cannabis%20Profits%20Daily%20Question) Website: []( Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. [Privacy Policy]( | [Terms & Conditions](